Coeheal
All articlesCancer Research

The Warburg Effect: Why Cancer Cells Love Sugar

10 min readMay 18, 2026By M. Santos

In 1924, Otto Warburg discovered that cancer cells metabolize glucose differently from normal cells. A century later, this insight is reshaping cancer treatment.

Evidence qualityMixed evidence — mechanism established, dietary therapy emerging

The Warburg Effect is established cancer biology. Ketogenic diet as adjunct cancer therapy is an active research area with promising but preliminary clinical evidence.

For educational purposes only — not medical advice. How we evaluate evidence →

Mechanism established — dietary therapy emerging

The Warburg Effect is established cancer biology. Ketogenic diet as an adjunct cancer therapy is an active research area, but the clinical evidence is preliminary. It should not replace standard oncology care.

This article covers the established science and the emerging clinical research — not a treatment protocol.

Always consult a qualified physician or oncologist before making any changes to your treatment plan. This article is for informational purposes only and does not constitute medical advice, a diagnosis, or a treatment recommendation.

Written by

M. Santos

Health science researcher and medical writer

Reviewed by

Dr. A. Ferreira, MD

General practitioner with integrative medicine training. Reviewed for factual accuracy. Ketogenic diet as cancer therapy is an active research area; it is not a standard-of-care treatment.

Last reviewed

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Our editorial standards →

In 1924, German biochemist Otto Warburg made a discovery that would earn him the Nobel Prize in Physiology or Medicine in 1931 and remain one of the most debated observations in cancer biology for a century: cancer cells preferentially ferment glucose into lactate even in the presence of abundant oxygen — a phenomenon he called aerobic glycolysis, now known as the Warburg Effect. Normal cells use oxidative phosphorylation (OXPHOS) in the mitochondria to efficiently extract energy from glucose, producing approximately 36 ATP molecules per glucose molecule. Cancer cells, by contrast, use the far less efficient glycolytic pathway, producing only 2 ATP per glucose — but they compensate by consuming glucose at dramatically higher rates.

Why Would Cancer Cells Choose an Inefficient Pathway? The Warburg Effect initially seemed paradoxical — why would rapidly dividing cells choose a less efficient energy pathway? Modern research has revealed that the Warburg Effect is not merely a metabolic quirk but a strategic adaptation that provides cancer cells with multiple advantages: it generates biosynthetic precursors (amino acids, nucleotides, lipids) needed for rapid cell division; it creates an acidic microenvironment that suppresses immune function and promotes invasion; and it may reflect underlying mitochondrial dysfunction that forces reliance on glycolysis.

The Ketogenic Diet as a Metabolic Cancer Therapy. The Warburg Effect has inspired the hypothesis that a ketogenic diet — which dramatically reduces glucose availability by restricting carbohydrates and replacing them with fat — could selectively starve cancer cells while sparing normal cells. Normal cells can readily switch to burning ketone bodies (produced from fat) for energy; cancer cells, with their impaired mitochondria and dependence on glucose, may be less able to make this metabolic switch. This is the 'metabolic theory of cancer' associated with researchers like Dr. Thomas Seyfried at Boston College.

Preclinical and Clinical Evidence

The preclinical evidence for ketogenic diets as a cancer therapy is substantial: multiple animal studies have shown tumor growth inhibition and improved survival with ketogenic diets, particularly for brain cancers (glioblastoma) and certain other tumor types. Clinical evidence is more limited but growing. A 2021 pilot study in Nature Medicine found that a ketogenic diet combined with standard chemotherapy was safe and feasible in glioblastoma patients and showed signals of improved outcomes.

Practical Implications: Reducing Sugar and Refined Carbohydrates

Even without adopting a full ketogenic diet, the Warburg Effect provides a compelling rationale for cancer patients to minimize sugar and refined carbohydrate intake. Elevated blood glucose and insulin are associated with worse cancer outcomes across multiple tumor types. A diet emphasizing non-starchy vegetables, quality proteins, healthy fats, and minimal refined carbohydrates is broadly supported by the evidence.

⚕️ Disclaimer: The ketogenic diet as a cancer therapy is an area of active research but is not yet established as a standard of care. Cancer patients should not adopt extreme dietary changes without consulting their oncology team, as some dietary interventions may interact with treatment. This article is for educational purposes only.

Personalised plan

Healthy Aging Plan

Build a personalised plan for long-term health and prevention.

Get your personalised plan

Seen a claim you want to verify?

The Claim Decoder grades the evidence behind any natural health claim — A to F, with sources.

A— Strong RCTsB— Good evidenceC— Mixed studiesD— Weak evidenceF— No human data

Suggested from this article:

"High-dose vitamin C can treat cancer"

Prompted by: The Warburg Effect: Why Cancer Cells Love Sugar